Dose-Levels and First Signs of Efficacy in Contemporary Oncology Phase 1 Clinical Trials

di Ferte, Charles, Soria, Jean-Charles, Penel, Nicolas
Pubblicazione 2011

Predictive Value of Clinical Judgment of Tumour Progression in Phase II Trials

di Kotecki, Nuria, Penel, Nicolas, Adenis, Antoine, Ferte, Charles, Clisant, Stéphanie
Pubblicazione 2012

Exomics and immunogenics: Bridging mutational load and immune checkpoints efficacy

di Champiat, Stéphane, Ferté, Charles, Lebel-Binay, Sophie, Eggermont, Alexander, Soria, Jean Charles
Pubblicazione 2014

rCGH: a comprehensive array-based genomic profile platform for precision medicine

di Commo, Frederic, Guinney, Justin, Ferté, Charles, Bot, Brian, Lefebvre, Celine, Soria, Jean-Charles, André, Fabrice
Pubblicato in Bioinformatics (2016)

The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features

di Limkin, Elaine Johanna, Reuzé, Sylvain, Carré, Alexandre, Sun, Roger, Schernberg, Antoine, Alexis, Anthony, Deutsch, Eric, Ferté, Charles, Robert, Charlotte
Pubblicato in Sci Rep (2019)

Development and Validation of a Bedside Score to Predict Early Death in Cancer of Unknown Primary Patients

di Penel, Nicolas, Negrier, Sylvie, Ray-Coquard, Isabelle, Ferte, Charles, Devos, Patrick, Hollebecque, Antoine, Sawyer, Michael B., Adenis, Antoine, Seve, Pascal
Pubblicazione 2009

Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence

di Dercle, Laurent, Ammari, Samy, Bateson, Mathilde, Durand, Paul Blanc, Haspinger, Eva, Massard, Christophe, Jaudet, Cyril, Varga, Andrea, Deutsch, Eric, Soria, Jean-Charles, Ferté, Charles
Pubblicato in Sci Rep (2017)

Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in Oncology

di Ferté, Charles, Trister, Andrew D., Huang, Erich, Bot, Brian M., Guinney, Justin, Commo, Frederic, Sieberts, Solveig, André, Fabrice, Besse, Benjamin, Soria, Jean-Charles, Friend, Stephen H.
Pubblicazione 2013

Tumor Growth Rate (TGR) is an early indicator of anti-tumor drug activity in phase I clinical trials

di Ferté, Charles, Fernandez, Marianna, Hollebecque, Antoine, Koscielny, Serge, Levy, Antonin, Massard, Christophe, Balheda, Rastislav, Bot, Brian, Gomez-Roca, Carlos, Dromain, Clarisse, Ammari, Samy, Soria, Jean-Charles
Pubblicazione 2013

IGF-1R targeting increases the antitumor effects of DNA damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy

di Ferté, Charles, Loriot, Yohann, Clémenson, Céline, Commo, Frederic, Gombos, Andrea, Bibault, Jean-Emmanuel, Fumagalli, Ingrid, Hamama, Saad, Auger, Nathalie, Lahon, Benoit, Chargari, Cyrus, Calderaro, Julien, Soria, Jean-Charles, Deutsch, Eric
Pubblicazione 2013

Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types

di Martin‐Romano, Patricia, Castanon, Eduardo, Ammari, Samy, Champiat, Stéphane, Hollebecque, Antoine, Postel‐Vinay, Sophie, Baldini, Capucine, Varga, Andrea, Michot, Jean Marie, Vuagnat, Perrine, Marabelle, Aurélien, Soria, Jean‐Charles, Ferté, Charles, Massard, Christophe
Pubblicato in Cancer Med (2020)

TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen

di Marquard, Andrea Marion, Birkbak, Nicolai Juul, Thomas, Cecilia Engel, Favero, Francesco, Krzystanek, Marcin, Lefebvre, Celine, Ferté, Charles, Jamal-Hanjani, Mariam, Wilson, Gareth A., Shafi, Seema, Swanton, Charles, André, Fabrice, Szallasi, Zoltan, Eklund, Aron Charles
Pubblicato in BMC Med Genomics (2015)

High incidence of cetuximab-related infusion reactions in head and neck patients

di Palomar Coloma, Virginia, Bravo, Pamela, Lezghed, Naima, Mayache-Badis, Lamia, Herrera Gómez, Ruth Gabriela, Iacob, Mariana, Nicouleau, Laurence, Desmaris, Romain, Tao, Yungan, Leibu, Cristian, Matias, Margarida, Lemare, Francois, Even, Caroline, Annereau, Maxime, Ferté, Charles
Pubblicato in ESMO Open (2018)

Modeling RAS phenotype in colorectal cancer uncovers novel molecular traits of RAS dependency and improves prediction of response to targeted agents in patients

di Guinney, Justin, Ferté, Charles, Dry, Jonathan, McEwen, Robert, Manceau, Gilles, Kao, KJ, Chang, Kai-Ming, Bendtsen, Claus, Hudson, Kevin, Huang, Erich, Dougherty, Brian, Ducreux, Michel, Soria, Jean-Charles, Friend, Stephen, Derry, Jonathan, Laurent-Puig, Pierre
Pubblicazione 2013

Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors

di Siu, Lillian, Brody, Joshua, Gupta, Shilpa, Marabelle, Aurélien, Jimeno, Antonio, Munster, Pamela, Grilley-Olson, Juneko, Rook, Alain H, Hollebecque, Antoine, Wong, Rebecca K S, Welsh, James W, Wu, Yuling, Morehouse, Christopher, Hamid, Oday, Walcott, Farzana, Cooper, Zachary A, Kumar, Rakesh, Ferté, Charles, Hong, David S
Pubblicato in J Immunother Cancer (2020)

Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells

di Sun, Roger, Sundahl, Nora, Hecht, Markus, Putz, Florian, Lancia, Andrea, Rouyar, Angela, Milic, Marina, Carré, Alexandre, Battistella, Enzo, Alvarez Andres, Emilie, Niyoteka, Stéphane, Romano, Edouard, Louvel, Guillaume, Durand-Labrunie, Jérôme, Bockel, Sophie, Bahleda, Rastilav, Robert, Charlotte, Boutros, Celine, Vakalopoulou, Maria, Paragios, Nikos, Frey, Benjamin, Soria, Jean-Charles, Massard, Christophe, Ferté, Charles, Fietkau, Rainer, Ost, Piet, Gaipl, Udo, Deutsch, Eric
Pubblicato in J Immunother Cancer (2020)

Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

di Ferrara, Roberto, Mezquita, Laura, Texier, Matthieu, Lahmar, Jihene, Audigier-Valette, Clarisse, Tessonnier, Laurent, Mazieres, Julien, Zalcman, Gerard, Brosseau, Solenn, Le Moulec, Sylvestre, Leroy, Laura, Duchemann, Boris, Lefebvre, Corentin, Veillon, Remi, Westeel, Virginie, Koscielny, Serge, Champiat, Stephane, Ferté, Charles, Planchard, David, Remon, Jordi, Boucher, Marie-Eve, Gazzah, Anas, Adam, Julien, Bria, Emilio, Tortora, Giampaolo, Soria, Jean-Charles, Besse, Benjamin, Caramella, Caroline
Pubblicato in JAMA Oncol (2018)

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

di Berry, Sneha, Giraldo, Nicolas, Nguyen, Peter, Green, Benjamin, Xu, Haiying, Ogurtsova, Aleksandra, Soni, Abha, Succaria, Farah, Wang, Daphne, Roberts, Charles, Stein, Julie, Engle, Elizabeth, Pardoll, Drew, Anders, Robert, Cottrell, Tricia, Taube, Janis M., Tran, Ben, Voskoboynik, Mark, Kuo, James, Bang, Yung-Lue, Chung, Hyun-Cheo, Ahn, Myung-Ju, Kim, Sang-We, Perera, Ayesh, Freeman, Daniel, Achour, Ikbel, Faggioni, Raffaella, Xiao, Feng, Ferte, Charles, Lemech, Charlotte, Meric-Bernstam, Funda, Werner, Theresa, Hodi, Stephen, Messersmith, Wells, Lewis, Nancy, Talluto, Craig, Dostalek, Mirek, Tao, Aiyang, McWhirter, Sarah, Trujillo, Damian, Luke, Jason, Xu, Chunxiao, BoMarelli, Qi, Jin, Qin, Guozhong, Yu, Huakui, Jenkins, Molly, Lo, Kin-Ming, Halle, Joern-Peter, Lan, Yan, Taylor, Matthew, Vogelzang, Nicholas, Cohn, Allen, Stepan, Daniel, Shumaker, Robert, Dutcus, Corina, Guo, Matthew, Schmidt, Emmett, Rasco, Drew, Brose, Marcia, Vogelzang, Nicholas, Di Simone, Christopher, Jain, Sharad, Richards, Donald, Encarnacion, Carlos, Rasco, Drew, Shumaker, Robert, Dutcus, Corina, Stepan, Daniel, Guo, Matthew, Schmidt, Emmett, Taylor, Matthew, Vogelzang, Nicholas, Encarnacion, Carlos, Cohn, Allen, Di Simone, Christopher, Rasco, Drew, Richards, Donald, Taylor, Matthew, Dutcus, Corina, Stepan, Daniel, Shumaker, Robert, Guo, Matthew, Schmidt, Emmett, Mier, James, An, Jeongshin, Yang, Yeun-yeoul, Lee, Won-Hee, Yang, Jinho, Kim, Jong-kyu, Kim, Hyun Goo, Paek, Se Hyun, Lee, Jun Woo, Woo, Joohyun, Kim, Jong Bin, Kwon, Hyungju, Lim, Woosung, Paik, Nam Sun, Kim, Yoon-Keun, Moon, Byung-In, Janku, Filip, Tan, David, Martin-Liberal, Juan, Takahashi, Shunji, Geva, Ravit, Gucalp, Ayca, Chen, Xueying, Subramanian, Kulandayan, Mataraza, Jennifer, Wheler, Jennifer, Bedard, Philippe
Pubblicato in J Immunother Cancer (2019)